Interment will follow in the Koontz Church of the Brethren Cemetery. Funeral services will be held Saturday, Apat 11 AM at the Koontz Church of the Brethren. Visitation will be held Friday, April 5, 2019, from 6-8 PM and Saturday, Apfrom 10-11AM at the Koontz Church of the Brethren. He is survived by his two children: Alan Robert Koontz (Trudy) of RD New Enterprise and Debra Lee Koontz Roberson (Joe) of Screven, GA three grandsons: Mark Koontz, Joel Koontz, both of RD New Enterprise, and Matthew Traverso of Morgantown, WV and one brother, Bernard Koontz of Carlisle, PA sister-in-law Blanche Koontz of Bedford brother-in-law John Stanley of Everett and numerous nieces and nephews. He was preceded in death by siblings Florence, Thelma, John, William, and Jake and his beloved wife, who he married on December 11, 1953, Mary Audrey Stanley Koontz, who passed away on November 3, 2012. He enjoyed history, and movies and books about WWII. He was a long-time member of the Koontz Church of the Brethren. He was a one-time member of the Lions’ Club, and a board member of the Dairy Herd Improvement Association (DHIA). He returned to assume operation of the family dairy farm which he went on to manage and operate most of his life. In his youth, he was a veterinary assistant in Bedford County before traveling to California, then working as a farmhand on a farm in Iowa for a couple years. Robert was a graduate of Replogle High School, Class of 1947. He was born Jin the home where he later would live and farm most of his life, to the late Wilson Koontz and the late Edith Smith Koontz. All rights reserved.Robert Clair Koontz, 89, of RD New Enterprise, died Apat UPMC Altoona. UK NIHR Health Technology Assessment programme, Pfizer, BUPA Foundation, and J P Moulton Charitable Foundation.Ĭopyright 2010 Elsevier Ltd. On the basis of these results, tranexamic acid should be considered for use in bleeding trauma patients. Tranexamic acid safely reduced the risk of death in bleeding trauma patients in this study. The risk of death due to bleeding was significantly reduced (489 vs 574 relative risk 0.85, 95% CI 0.76-0.96 p=0.0077). All-cause mortality was significantly reduced with tranexamic acid (1463 tranexamic acid group vs 1613 placebo group relative risk 0.91, 95% CI 0.85-0.97 p=0.0035). This study is registered as ISRCTN86750102, NCT00375258, and South African Clinical Trial RegisterDOH-27-0607-1919.ġ0 096 patients were allocated to tranexamic acid and 10 115 to placebo, of whom 10 060 and 10 067, respectively, were analysed. The primary outcome was death in hospital within 4 weeks of injury, and was described with the following categories: bleeding, vascular occlusion (myocardial infarction, stroke and pulmonary embolism), multiorgan failure, head injury, and other. ![]() Both participants and study staff (site investigators and trial coordinating centre staff) were masked to treatment allocation. Randomisation was balanced by centre, with an allocation sequence based on a block size of eight, generated with a computer random number generator. ![]() 20 211 adult trauma patients with, or at risk of, significant bleeding were randomly assigned within 8 h of injury to either tranexamic acid (loading dose 1 g over 10 min then infusion of 1 g over 8 h) or matching placebo. This randomised controlled trial was undertaken in 274 hospitals in 40 countries. ![]() ![]() We assessed the effects of early administration of a short course of tranexamic acid on death, vascular occlusive events, and the receipt of blood transfusion in trauma patients. Tranexamic acid can reduce bleeding in patients undergoing elective surgery.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |